label class label 2
classes | id stringlengths 14 38 | original_id stringlengths 12 35 | text stringlengths 518 8.49k | __index_level_0__ int64 0 5 |
|---|---|---|---|---|
1cons | 61039071.txt_0 | 61039071.txt | Blackstar Investors PLC Annual Report and Accounts 2007
Highlights
· Net asset value ("NAV") up to 133 pence per share. · Investment portfolio performed strongly in the
period under review. · In the 24 months since inception, Blackstar has
generated total gross returns of 51%. · Repurchased 2.8 million shares at an a... | 0 |
1cons | 61039071.txt_1 | 61039071.txt | half of 2007, Blackstar has managed to deliver an excellent set of results increasing its NAV per share from 101p at 31 December 2006 to 133p at year end. The underlying investments performed well over the period under review showing, that despite world market weakness, the infrastructure story in South Africa remains... | 1 |
1cons | 61039071.txt_2 | 61039071.txt | share buyback of 2.8 million shares.
During the year Blackstar made strong inroads into developing the fees and income side of the business, generating fee income and dividend receipts of £1.1 million during the financial year. Blackstar Managers generates fees through providing advisory and corporate finance services... | 2 |
1cons | 61039071.txt_3 | 61039071.txt |
2
Blackstar Annual Report and Accounts 2007
" South Africa is an important market within the emerging market spectrum, given its strong resources and capital investment programme."
South Africa's good economic performance continued during the financial year, despite a rise in interest rates and inflation. In the ... | 3 |
1cons | 61039071.txt_b0 | 61039071.txt | inserting the name of your chosen proxy, then the Chairman of the Meeting will act as your proxy. 2. The manner in which the proxy is to vote should be indicated by marking either `'For'', `'Against'' or "Withheld"; if neither is marked, the proxy will vote or abstain at his/her discretion. The "Withheld" option is pr... | 4 |
1cons | 61039071.txt_b1 | 61039071.txt | To grant a discharge to the statutory auditor in respect of the execution of his mandate to 31 December 2007.
17 To grant a discharge to the independent auditors in respect of the execution of their mandate to 31 December 2007.
18 To approve the continuation of the current investment strategy.
Against
Withheld
Pl... | 5 |
1cons | 61851206.txt_0 | 61851206.txt | Proton Power Systems PLC Annual Report 2012
Technology based on competence
Proton Power Systems plc CONTENTS
Chairman and CEO's statement
2
Board of Directors
5
Shareholder information
8
Operating and financial review
9
Directors' report
17
Remuneration report
28
Nominations committee report
31
Audit a... | 0 |
1cons | 61851206.txt_1 | 61851206.txt | has now successfully completed more than 10,000
hours of start/stop operation First installation of the 5kW PM Module within an EON power station in cooperation with
Modl Cooperation agreement signed with Modl for the development and production of a fully
integrated fuel cell stationary power system Receipt of an o... | 1 |
1cons | 61851206.txt_2 | 61851206.txt | 220 km) with energy from the batteries and the fuel cell Range Extender. The SEV Newton truck has also participated in several road shows, presenting electric vehicles to logistics companies. A larger fuel cell Range Extender for electric urban buses and other mobile applications is now under development. A project is... | 2 |
1cons | 61851206.txt_3 | 61851206.txt | maritime sector for the fuel cell system for several ship projects, mainly inland tourist and ferry boats as well as coast guard ships. The maritime market is seen as a longer term opportunity. The Group successfully completed development of the new 25kW fuel cell stack. The new stack will be used in all three market ... | 3 |
1cons | 61851206.txt_b0 | 61851206.txt | given to a previously appointed proxy, must, in order to be valid, be transmitted so as to be received by the issuer's agent (ID 7RA11) by the latest time(s) for receipt of proxy appointments specified in this notice. For this purpose, the time of receipt will be taken to be the time (as determined by the timestamp ap... | 4 |
1cons | 61851206.txt_b1 | 61851206.txt | (but not including non working days) before the time for holding any adjourned meeting or in the case of a poll not taken on the same day as the meeting or adjourned meeting for the taking of the poll at which it is to be used or lodged using the CREST proxy voting service - see below.
6CREST members who wish to appoi... | 5 |
1cons | 60309985.txt_0 | 60309985.txt | Operating highlights
Turnover of £283m (2001:£323m). Profit before tax* unchanged at £30.1m. Significant improvement in operating margin* to 13.1% (2001:11.8%). Subscriptions resilient and are now the Group's largest single revenue stream at 35% of total revenue.
*Before goodwill amortisation and exceptional items.
Re... | 0 |
1cons | 60309985.txt_1 | 60309985.txt | Cameron McKenna Registrars Lloyds TSB Registrars The Causeway Worthing West Sussex BN99 6DA Shareholder Services Helpline: 0870 600 3964
Lloyd's is the trade mark of the Society incorporated by the Lloyd's Act 1871 by the name of Lloyd's
Financial highlights
Turnover (£m) Earnings before interest, tax, depreciation,... | 1 |
1cons | 60309985.txt_2 | 60309985.txt | 45,097 46,705 27,492 31,226
905
Underlying operating profit/ (loss) by market sector
Finance and Insurance Telecoms and Media Law and Tax Maritime, Trade and Transport Life Sciences Commodities and Energy Other
(£000)
12,135 9,301 4,737 2,379 5,308 3,615 (220)
Turnover by location of customer
United Kingdom Contine... | 2 |
1cons | 60309985.txt_3 | 60309985.txt | %
1999
15.7%
1998
14.3%
Informa Annual Report 2002
2
Underlying operating profit
2002 2001 2000 1999 1998
(£m)
37.3 38.1 46.8 35.7 29.0
About Informa
Telecoms and Media Informa is the number one provider worldwide of information to the mobile telecommunications industry using a diverse range of media includin... | 3 |
1cons | 60309985.txt_b0 | 60309985.txt | on the London Stock Exchange website or by visting our website at www.informa.com.
Shareview Portfolio Service The Shareview Portfolio service from our registrars gives you more online information about your shares and other investments. To register for your portfolio at www.shareview.co.uk you will need your shareho... | 4 |
1cons | 60309985.txt_b1 | 60309985.txt | .
Informa Annual Report 2002
46
Informa Annual Report 2002
47
Shareholder Information
Contact details Registered Office: Mortimer House, 37/41 Mortimer Street, London W1T 3JH Tel: 020 7017 5000 Fax: 020 7017 4286 Website address: www.informa.com Email: shareholder.enquiries@informa.com
Enquiring about your shar... | 5 |
1cons | 60636900.txt_0 | 60636900.txt | Annual Report 2004
Highlights
January 2004 Change in leadership at euromicron subsidiaries The subsidiaries EUROMICRON Werkzeuge GmbH and euromicron systems GmbH start the fiscal year under new management. The long-serving General Managers Hans Theis and Bernd Köhler retire. Dr. Jürgen Nehler and Michael Theis are ... | 0 |
1cons | 60636900.txt_1 | 60636900.txt | eland-Palatinate and Thuringia in the field of communications and security technology.
June 2004 General Meeting in Frankfurt/Main Consolidated sales and return on sales reach the level of the previous year. euromicron closes fiscal 2003 successfully at the General Meeting in Frankfurt and decides to pay a dividend o... | 1 |
1cons | 60636900.txt_2 | 60636900.txt | EX in Dubai Following its first successful appearance at this trade show in the United Arab Emirates in 2003, the euromicron Group once more presents its expanded product portfolio at the joint German stand.
November 2004 Successful presence at exponet in Cologne The euromicron Group presents itself at exponet in Col... | 2 |
1cons | 60636900.txt_3 | 60636900.txt | ratio Employees (number as an average for the year)
2004 m.
110.8
2003 m.
134.5
72.6
51.5
38.2
83.0
97.3
104.3
7.1
10.4
6.4
19.8
9.7
15.6
6.9 4.0 -1.2 4.0 4.6 4,660 0.86 0.99 107.9 59.8% 765
5.8 6.1 3.7 12.1 8.6 4,660 2.59 1.85 124.1 50.4% 997
The euromicron Group with its more than 700 employees i... | 3 |
1cons | 60636900.txt_b0 | 60636900.txt | be established by means of special active components so that it acts like a virtual private network (VPN) within the entire Internet. This virtual private network can then be protected so as to prevent external intrusion by unauthorized persons outside the VPN. The security zone created in this way within the generall... | 4 |
1cons | 60636900.txt_b1 | 60636900.txt | internet use and image transfer). Transfer rates of up to 2 Mbit/second are possible with this system.
URM® Short name for an innovative fiber optic cable connector produced by EUROMICRON Werkzeuge GmbH: YOU ARE Modular. Duplex fiber optic cable connectors built as modules; max. up to 8 fibers; small form factor (SFF) ... | 5 |
1cons | 61619548.txt_0 | 61619548.txt | Terrace Hill Group plc
Annual Report and Accounts 2011
Company overview 01 Highlights 02 Company overview
02 Terrace Hill at a glance 04 Chairman's statement Business review 06 Business review 06 Operations 10 Finance 14 Risk management
Corporate governance 16 Corporate social responsibility 18 Board of directors an... | 0 |
1cons | 61619548.txt_1 | 61619548.txt | terracehill.co.uk
Highlights
Financial highlights: -- Revenue profit of £5.6 million (30 September 2010: loss of £3.0 million)
--Revenue of £67.8 million (30 September 2010: £30.7 million)
--Loss before tax (IFRS) of £10.2 million (30 September 2010 restated: profit of £17.9 million)
--EPRA Net Asset Value per share d... | 1 |
1cons | 61619548.txt_2 | 61619548.txt | progress with other developments, including two central London office-led mixed-use schemes at Howick Place in Victoria, and Savile Row/Conduit Street, W1
--Orderly disposal of residential portfolio underway with a 1218 month sales process expected
25 years of terrace hill
Terrace Hill was founded in 1986 by Robert A... | 2 |
1cons | 61619548.txt_3 | 61619548.txt | .6
26.6
07 08
* restated
09* 10* 11
02 Terrace Hill Group plc Annual Report and Accounts 2011
Company overview Terrace Hill at a glance
Turning Opportunity into Profit
1 It's what you know and who you know
5 4
3
Our regional office network gives us the geographical spread throughout the UK to source local oppor... | 3 |
1cons | 61619548.txt_b0 | 61619548.txt | Annual Report and Accounts 2011
Shareholder information
Shareholder analysis as at 30 September 2011
Size of holding
11,000 1,00110,000 10,001100,000 100,0011,000,000 1,000,001 and over
London Stock Exchange The ordinary shares of the company are traded on AIM with code THG.
Share price (pence per ordinary shar... | 4 |
1cons | 61619548.txt_b1 | 61619548.txt | ven months ended 30 September 2010 Restated
30,747 17,874 (2,818) 15,056
-- 7.14 7.14 34.50 211,971,299 18.25
IFRS
Year ended 31 October 2009
Restated
29,065 (61,919)
3,135 (58,784)
-- (27.87) (27.87) 26.56 211,971,299 17.00
Year ended 31 October 2008
63,366 (31,602)
4,327 (27,275)
1.34 (12.90) (12.90) 53.39 211,971,... | 5 |
1cons | 61645582.txt_0 | 61645582.txt | ANNUAL REPORT 2011
ON THE PATH TO MARKET MATURITY
BY PEOPLE. WITH PEOPLE. FOR PEOPLE.
:: BY PEOPLE. WITH PEOPLE. FOR PEOPLE.
4SC researches and develops innovative, orally administered small-molecule drugs for autoimmune diseases and cancer indications with a high unmet medical need and excellent marketing potentia... | 0 |
1cons | 61645582.txt_1 | 61645582.txt | ral autoimmune modulator of the DHODH enzyme and the IL-17 cytokine
Oral autoimmune modulator of the DHODH enzyme and the IL-17 cytokine
ONCOLOGY Resminostat 4SC-201 Resminostat 4SC-201 Resminostat 4SC-201 4SC-202
4SC-203
4SC-205
Hepatocellular Carcinoma (HCC)
Oral pan histone deacetylase (HDAC) inhibitor
Hodgkin's... | 1 |
1cons | 61645582.txt_2 | 61645582.txt | 207
Solid Tumours
Oral cell-cycle blocker
RESEARCH PROGRAMMES
Cancer stem cells
Oncology
Ion channel blockers
Autoimmun Disease
Cytokine modulation
Autoimmun Disease/ Oncology
Completed clinical studies
Ongoing clinical studies
Further clinical studies planned
PHASE II
PHASE III
MARKET APPROVAL / MARKET ... | 2 |
1cons | 61645582.txt_3 | 61645582.txt | extra) (in ) Closing price on balance sheet date (in ) Market capitalisation on balance sheet date (in 000's) Average daily trading volume (Xetra) (shares)
2011
780 - 18,793 - 19,071
23,533 73.9% 31,838 - 9,216 11,080 1,864 6,820 15,820
96
- 0.46 41,455 26,4%
4.89 1.20 1.23 51,621 26,307
2010
989 - 20,271 - 20,075
31... | 3 |
1cons | 61645582.txt_b0 | 61645582.txt | four categories of financial instruments.
:: E
EQUITY METHOD :: Method used in annual financial statements to account for an entity's investment in another entity's voting capital.
ESOP : : Abbreviation for employee stock option programme.
:: F
FIFO METHOD : : Abbreviation for"first in, first out"; a procedure relate... | 4 |
1cons | 61645582.txt_b1 | 61645582.txt | / Sector Glossary :: 121
:: A
AFS : : Abbreviation for available for sale, one of four categories of financial instruments.
AFVPL : : Abbreviation for at fair value through profit or loss, one of four categories of financial instruments.
AMORTISED COST : : In accordance with IAS 39, financial instruments in the categ... | 5 |
1cons | 60785439.txt_0 | 60785439.txt | 2005
INDUS HOLDING AG AT A GLANCE
Parent Company
2001
2002
2003
2004
2005
Income from investments EBIT Net profit Total assets Fixed assets Capital stock Equity Equity ratio
EUR in millions EUR in millions EUR in millions EUR in millions EUR in millions EUR in millions EUR in millions %
73.6 71.6 56.2 715.5 ... | 0 |
1cons | 60785439.txt_1 | 60785439.txt | BIT Net income Depreciation Total assets Equity Equity ratio Employees
Holding company Portfolio companies
EUR in millions % EUR in millions EUR in millions EUR in millions EUR in millions EUR in millions %
589.2 32.0 53.9 22.0 51.1
594.4 142.4
24.0 4,053
12 4,041
680.3 35.0 54.2 10.5 61.3
678.8 137.4
20.2 4,484... | 1 |
1cons | 60785439.txt_2 | 60785439.txt | improve comparability, key performance indicators for 2004 were adjusted to comply with IFRS as well. Therefore, figures for the previous year (2004) may deviate from the ones published in the last annual report.
Share
2001
2002
2003
2004
2005
Market capitalization Earnings per share (parent company) Earnings p... | 2 |
1cons | 60785439.txt_3 | 60785439.txt |
8
Status of INDUS Holding AG
11
Group Accounting
13
Earnings Situation
13
Financial Position
14
Net Worth
15
Segment Report
16
Workforce
38
Environmental Protection
38
Research and Development Report
38
Events After the Balance Sheet Date
38
Risk Management
39
Outlook
42
Investor Relations
4... | 3 |
1cons | 60785439.txt_b0 | 60785439.txt | KAN INOX GmbH*, Hattingen
25.2
1.31
90%
59
* including subsidiaries ** CHF in millions *** The consolidated financial statements only disclose prorated revenue in accordance with IFRS.
FINANCIAL CALENDAR/IMPRINT
105
Balance Sheet Press Conference Analyst Conference Interim report on the first quarter Annual Sh... | 4 |
1cons | 60785439.txt_b1 | 60785439.txt |
Other Investments
M. BRAUN Inertgas-Systeme GmbH*, Garching
35.4
1.24
100%
157
HORN GmbH & Co. KG*, Flensburg
15.6
1.33
100%
98
MIKROP AG, Kronbühl/Switzerland
13.4 **
0.05 ** 100%
55
NEUTRASOFT GmbH & Co. KG*, Greven
39.0
1.85
100%
171
Oskar OVERMANN GmbH & Co. KG, Sinsheim
3.4
0.57
100%
29
H... | 5 |
1cons | 60879280.txt_0 | 60879280.txt | GW Pharmaceuticals plc
Annual Report & Accounts 2006
GW Pharmaceuticals plc is licensed by the UK Home Office to work with a range of controlled drugs for medical research purposes. The Group's lead programme is the development of a portfolio of cannabinoid medicines, including Sativex®, to meet patient needs in a wi... | 0 |
1cons | 60879280.txt_1 | 60879280.txt | FDA permitted Sativex to enter directly into US Phase III trials in Cancer Pain, allowing late stage US development to commence during 2007
US Sativex licensing discussions progressing on track
Further encouraging data from Phase III trials in MS Spasticity and Neuropathic Pain
Phase III MS Neuropathic Pain trial r... | 1 |
1cons | 60879280.txt_2 | 60879280.txt | is marketed in Canada and is the subject of Phase III clinical trials across Europe. Late stage trials are due to commence in the US shortly.
Leaders in cannabinoid science
Cannabinoid science is a new and fast emerging area of focus for the pharmaceutical industry. Through its unique access to cannabinoid starting m... | 2 |
1cons | 60879280.txt_3 | 60879280.txt | library of further cannabinoid targets which it aims to progress into clinical trials.
Working in partnership
GW has to date entered into two partnerships with large pharmaceutical companies, Almirall and Bayer HealthCare. We work closely with our partners to maximise the value of our research pipeline.
click to go... | 3 |
1cons | 60879280.txt_b0 | 60879280.txt |
58 GW Pharmaceuticals plc Annual Report & Accounts 2006
click to go to contents
25 Contingent Liabilities
There were no contingent liabilities at 30 September 2006 (2005: £nil).
26 Related Party Transactions
As stated in the Directors' Remuneration Report during the year the Group purchased services in the o... | 4 |
1cons | 60879280.txt_b1 | 60879280.txt | 438
19,875
23 Reconciliation of Net Cash Outflow to Movement in Net Funds
Increase/(decrease) in cash during the year Cash flow from change in lease financing Cash flow from movement in liquid resources
Movement in net funds during the year Net funds at start of year
Net funds at end of year
2006 £000's
2,525
4... | 5 |
1cons | 60470371.txt_0 | 60470371.txt | Big Yellow Group PLC
Annual Report & Accounts 2004
"AS WITH PREVIOUS YEARS, THE GROUP HAS ENJOYED CONTINUED GROWTH OVER THE YEAR, following strong trading
in the first half. In the second half we experienced the usual winter slowdown but I am pleased to report a robust pick up in trading in the fourth quarter,
w"Ahic... | 0 |
1cons | 60470371.txt_1 | 60470371.txt | ITABLE. We now have the
twin objectives of increasing earnings per share whilst maintaining a sustainable
eWxpEansBioEn pLroIEgrVamEmeT.HAT BIG YELLOW'S MARKET POSITION, BRANDING, CASH FLOW, ACCESS TO
CWAEPITBAELLAINEDVERETAHL AESTTABTIEGSYKEILLLSLOWW ILL'SALLOW UMSATROKAECTHIPEVOESTITHIEOSNE T, WBORAONBJDEICNTGIV,ESC.... | 1 |
1cons | 60470371.txt_2 | 60470371.txt | Debt 28 Company Balance Sheet 29 Notes to the Accounts 40 Five Year Summary ibc Officers and Professional Advisers
FINANCIAL HIGHLIGHTS
4th quarter 3rd quarter
ended
ended
31 Mar 04
31 Dec 03
%
Year
Year
ended
ended
31 Mar 04 31 Mar 03
%
Annualised revenue
£27.8m
£25.7m +8
Turnover
£6.6m
£6.3m +5
... | 2 |
1cons | 60470371.txt_3 | 60470371.txt | 1m
£1.3m +292
£1.2m (£2.3m)
0.66p
(2.11p)
20,400
13,800 +48
1,268k sq ft 875k sq ft +45
Maiden pre-tax profit of £1.2 million (2003: loss of £2.3 million)
Earnings from continuing operations for the year before exceptional items, depreciation, amortisation and tax of £5.1 million (2003: £1.3 million), (see note... | 3 |
1cons | 60470371.txt_b0 | 60470371.txt | Square footage occupied Number of customers Average number of employees during the year
2004 £'000
23,830 4,719 1,243
(3,834)
5,077
2003 £'000
15,579 (449)
(2,294) (2,643)
349
2002 £'000
8,408 (2,776) (2,306) (1,702)
(604)
2001 £'000
4,174 (2,909) (1,836)
(947)
(889)
2000 £'000
1,342 (1,649) (2,123)
(405)
(1,718)... | 4 |
1cons | 60470371.txt_b1 | 60470371.txt |
(11,699)
26,293
22,662
Net cash inflow from financing
26,126
10,963
(B) ANALYSIS OF NET DEBT
Cash at bank and in hand Bank overdraft Debt due after one year Total net debt
At 1 April 2003 £'000
2,267
Cash flow
£'000
(1,511) (267)
At 31 March
2004 £'000
756 (267)
2,267 (42,600)
(1,778)
(489)
(26,293) (68... | 5 |
1cons | 61191038.txt_0 | 61191038.txt | plethora SOLUT IONS
PLETHORA SOLUTIONS HOLDINGS plc ANNUAL REPORT AND ACCOUNTS
2008
CONTENTS
page
Highlights
3
Chairman's and Chief Executive's statement
4
Report of the Directors
9
Corporate governance statement
12
Report on remuneration
15
Report of the independent auditor
18
Group income statement
... | 0 |
1cons | 61191038.txt_1 | 61191038.txt | agreement, Sciele has made additional upfront payments of $8.4m · Sciele will also share development costs for PSD502 for non-US territories and pay a royalty on future revenues
to Plethora · Financial restructuring of the business, including a mutually satisfactory resolution with Paul Capital Healthcare
resulting in... | 1 |
1cons | 61191038.txt_2 | 61191038.txt | the last two years has been challenging for small healthcare businesses. Following the recent combination of transactions, cash resources have increased, gearing has been reduced and the Board believes that the Group is now in a position to enhance shareholder value.
PLETHORA SOLUTIONS ANNUAL REPORT AND ACCOUNTS 2008... | 2 |
1cons | 61191038.txt_3 | 61191038.txt | indication and a method of treatment which showed significant likelihood of achieving clinical efficacy.
In 2006, the Company acquired Timm Medical Technologies, Inc. (`Timm'); a US-based business which markets a medical device for the treatment of erectile dysfunction (ED). The acquisition of Timm was intended to pro... | 3 |
1cons | 61191038.txt_b0 | 61191038.txt | will receive low single digit royalties on the sales of PSD502 in Europe and a share of rest of the world income.
Also, on 26 May 2009, the Group announced a compromise with Paul Capital Healthcare for the release of the Group from all future liabilities under the Revenue Finance Agreement. As part of this compromise ... | 4 |
1cons | 61191038.txt_b1 | 61191038.txt | licensing fees. Out of the proceeds, the Group repaid £1.3 million being the amount drawn under the Sciele loan; and $6 million to Paul Capital Healthcare under the Revenue Finance Agreement; and £0.7 million to ETV Capital under the loan provided by them.
On 26 May 2009 the Group announced that it had entered into a ... | 5 |
1cons | 61320429.txt_0 | 61320429.txt | Business group figures
SMA Group Sales Export ratio Inverter output sold Capital expenditure1 Depreciation Operating profit (EBIT) Operating profit margin Consolidated net profit Earnings per share2 Employees (average during the period)3 in Germany abroad
SMA Group Total assets Equity Equity ratio Net working capital... | 0 |
1cons | 61320429.txt_1 | 61320429.txt | 2005 HGB 172.2 12.3% 344
7.0 3.0 35.2 20.4% 18.1 0.52 928 910 18
million million
million
million
12/31/2009 12/31/2008 12/31/2007 12/31/2006 12/31/2005
IFRS
IFRS
IFRS
IFRS
HGB
718.6
469.6
163.2
112.3
84.0
407.6
280.8
64.4
40.7
32.9
56.7%
59.8%
39.5%
36.2%
39.2%
98.6
78.0
59.4
34.3
22.6
1... | 1 |
1cons | 61320429.txt_2 | 61320429.txt | the SMA share 2009 percent5
Jan
Feb
Mar
Apr
May
Jun
Jul
SMA share
TecDax
ÖkoDax
250
200
150
100
50
Aug
Sep
Oct
Nov
Dec
1 excl. finance leases, excl. R&D 2 converted to 34,700,000 shares 3 incl. temporary employees 4 inventories and trade receivables minus trade payables 5 rebased to 100%
THE HE... | 2 |
1cons | 61320429.txt_3 | 61320429.txt | ung Warentest", the leading German consumer safety group.
Solar energy
Photovoltaic cells
solar inverters for every requirement worldwide
for all photovoltaics applications · grid connection · stand-alone power supply · backup operation
for any power class · from less than 1 kilowatt · up to the megawatt range
... | 3 |
1cons | 61320429.txt_b0 | 61320429.txt |
May 27, 2010
Annual General Meeting 2010, Kongress Palais Kassel
August 13, 2010
Publication of Half-yearly Financial Report January to June 2010 Analyst Conference Call: 9:00 a.m. (CET)
September 2010
Capital Markets Day, SMA/Niestetal
November 12, 2010
Publication of Quarterly Financial Report January to Sept... | 4 |
1cons | 61320429.txt_b1 | 61320429.txt | ," "will," "project" or words of similar meaning. Such statements are based on our current expectations and certain assumptions, and are, therefore, subject to certain risks and uncertainties. A variety of factors, many of which are beyond SMA's control, affect our operations, performance, business strategy and results... | 5 |
1cons | 60590700.txt_0 | 60590700.txt | Annual Report 2004
domnick hunter operates in 25 countries, manufactures in 6 countries and employs over 1,800 people.
The Group's operations are divided into two business segments:
Industrial Operations is a world leader in the provision of filters, dryers and ancillary equipment for the treatment of compressed air... | 0 |
1cons | 60590700.txt_1 | 60590700.txt | 06
domnick hunter group plc
Financial Review
20
Directors
22
Index to Directors' Report
and Financial Statements
23
Registered number: 2422827
Financial Highlights and Five Year Record
Turnover
2000 £000
102,975
For the year ended 31 December
2001 £000
120,040
2002 £000
122,960
2003 £000
136,892
2004 ... | 1 |
1cons | 60590700.txt_2 | 60590700.txt |
16.44p
16.82p
20.00p
23.38p
23.16p
(0.9)
Dividend per Ordinary share
8.65p
8.90p
9.40p
10.00p
10.50p
5.0
Cash flow from operations
9,654
12,135
15,989
16,361
14,372
(12.2)
1 Prior years figures have been restated following the adoption of UITF 38 (refer to page 38).
Turnover
02 domnick hunter gro... | 2 |
1cons | 60590700.txt_3 | 60590700.txt | again showed good underlying growth with a strong second half built on the previously reported confident start to the year. Most parts of the Group did well with a solid performance in Europe, buoyant sales in the Far East and strong demand in North America.
In April we acquired PTI Advanced Filtration Inc and PTI Tec... | 3 |
1cons | 60590700.txt_b0 | 60590700.txt | 2SF Tel: +44 (0) 191 410 5121 Fax: +44 (0) 191 410 4497 Company number: 2422827
REGISTRARS
Lloyds TSB Registrars The Causway Worthing West Sussex BN99 6DA Shareholder hotline: 0870 601 5366
ENQUIRIES
Administrative enquiries concerning shareholdings in the Company should be directed to the Registrars at the above ad... | 4 |
1cons | 60590700.txt_b1 | 60590700.txt | and that his commitment to the role is significant. It is also worthy of note that each of the other two independent non-executive directors has served on the Board for less than two years and that Mr Maudslay's knowledge and experience are important considerations in the Board's support of his standing for re-electio... | 5 |
1cons | 61057184.txt_0 | 61057184.txt | ANNUAL REPORT 2007
CONTENTS
Opening statement from the board of directors
4
Corporate Governance
6
Declaration of compliance
6
Report from the supervisory board
8
The company
10
Company profile
11
Company history
12
The board of directors
13
Corporate structure
14
Business areas
17
Overview of th... | 0 |
1cons | 61057184.txt_1 | 61057184.txt |
Outlook
47
Multiple year overview
49
Responsibility statement and closing declaration
50
Consolidated balance sheet
52
Consolidated profit and loss account
53
Consolidated cash flow statement
54
Consolidated statement of changes in shareholders` equity
55
Consolidated fixed assets financial year 2007
... | 1 |
1cons | 61057184.txt_2 | 61057184.txt | Investment Depreciation No. of employees
9.2 4.0 0.4 0.05 0.3 0.8 31.9 1.8 5.7%
28.8 8.3%
-6.9 5.2 27
Liabilities Obligations
24.3 3.7
2006
9.9 1.0 8.3
0
1.1 -0.9 -2.6 -0.13 -0.8 -0.9 21.6 0.2 0.9% 21.4 1.6% -0.7 2.0
28
18.8 4.3
2005
12.6 1.4
11.2 0
2.9 1.0 -0.2 -0.08 -0.5 0.9 27.8 1.0 4.0% 25.5 6.4% -2.7 2.0 34
... | 2 |
1cons | 61057184.txt_3 | 61057184.txt | 14.6 0
3.5 1.6 0.7 0.01
0 0.1 28.4 0.8 3.0%
26.3 4.0%
-0.4 1.9 39
3.3 1.4 0.5 0.09 0.5 0.1 28.7 0.9 3.0%
26.5 4.0%
-0.1 1.9 39
3.6 0.4 -1.0 -0.26 -1.5 -0.1 30.2 0.4 1.0%
28.6 2.0%
-0.8 3.3 46
24.3 7.8
22.5 7.8
25.1 9.0
2002 2001 *)
36.5 13.7 22.8
0
59.0 18.4 40.6
0
20.1 -8.1
0 -0.54
-9.3 0.2 51.3 1.6 3.0%
42.... | 3 |
1cons | 61057184.txt_b0 | 61057184.txt | the value of the goodwill reported in the consolidated balance sheet depends in particular on the levels of revenue and liquidity surplus shown in the management's corporate planning being realised.
MAZARS Hemmelrath GmbH Wirtschaftsprüfungsgesellschaft
Zelger Auditor
Munich, March 28, 2008
Kidalla Auditor
61
Ann... | 4 |
1cons | 61057184.txt_b1 | 61057184.txt | the scope of consolidation, the accounting and consolidation principles used and the main assessments made by the legal representatives, as well as the appraisal of the overall view of the consolidated financial statement and the corporate statement of affairs. In our view, our audit provides a sufficiently sure basis... | 5 |
1cons | 60499737.txt_0 | 60499737.txt | Direction de la Communication Groupe - 06/2004
BP 1 85707 POUZAUGES CEDEX - FRANCE TEL 00 33 (2) 51 66 32 32 FAX 00 33 (2) 51 65 82 33 e-mail : infos.finances@fleurymichon.fr http://www.fleurymichon.fr
2003 Business Review
CONTENTS
Group
Operational and Financial Organisation Chart Management Report Consolidated ... | 0 |
1cons | 60499737.txt_1 | 60499737.txt | Yves Gonnord CEO of the Management Board
Frédérick Bouisset
2003 consolidated turnover: 603 million Number of employees: 3,533
Eat-Out Solutions France
Graine d'Appétit Turnover: 1m Employees: 17
95%
Self-service restaurants
Solution Repas Automatique Turnover: 0.1m Employees: 4
Charcuterie Solutions
Fleury Michon C... | 1 |
1cons | 60499737.txt_2 | 60499737.txt | Production of ready-to-eat charcuterie and pâtés Meat deboning
Logistics Services
Fleury Michon Logistique
Turnover: 1.5m Employees: 278
100%
Group order rocessing
and logistics
International Operations
Regional Foods Development
Turnover: 7.5m Employees: 11
100%
Marketing of Fleury Michon products in Europe and the ... | 2 |
1cons | 60499737.txt_3 | 60499737.txt | 's particularly difficult international environment, which weighed on economic growth, Fleury Michon drove further market share gains in the strategic Ham and Prepared Meals businesses, thereby improving profits in line with forecasts.
2 BUSINESS REVIEW
2.1 OPERATING HIGHLIGHTS Selective growth, focused on core bu... | 3 |
1cons | 60499737.txt_b0 | 60499737.txt | to carry out a share buyback programme governed by article L 225-209 of the Commercial Code. The number of shares held by the Company at any given time may not exceed 10% of the capital. The authorisation may be used to:
- Stabilise the Fleury Michon share price, if necessary, by trading against the market.
- Purchase... | 4 |
1cons | 60499737.txt_b1 | 60499737.txt | ividends will be paid as from 10 June 2004. The General Meeting takes note of this proposal.
69 Proposed Resolutions
In accordance with article 243 bis of the General Tax Code, the General Meeting notes that dividend payments for the last three years, in euros, were as follows:
YEAR
2000 2001 2002
NUMBER OF SHARES... | 5 |
1cons | 60806922.txt_0 | 60806922.txt | ITRAIN PLC FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2005
Company no 3786948
ITRAIN PLC FINANCIAL STATEMENTS For the year ended 31 December 2005
Company registration number: Registered office: Directors:
Secretary: Bankers: Solicitors:
Auditors:
Nominated Advisors: Brokers: Registrars:
3786948
The Corn Ex... | 0 |
1cons | 60806922.txt_1 | 60806922.txt | ton Registrars Limited PO Box 30 Cresta House Alma Street Luton LU1 2PU
ITRAIN PLC FINANCIAL STATEMENTS For the year ended 31 December 2005
INDEX
CHAIRMAN'S STATEMENT.................................................................................................................. 2 REPORT OF THE DIRECTORS............... | 1 |
1cons | 60806922.txt_2 | 60806922.txt | major new key contract our largest ever.
Last year, iTrain continued to produce further turnover growth, higher profits, forge important new commercial partnerships and introduce a host of additional products. In terms of sales and profits, iTrain's turnover increased to £1,829,645, an increase of 67 per cent (2004:... | 2 |
1cons | 60806922.txt_3 | 60806922.txt | and IT technical expertise.
The effectiveness of our growth strategy is being borne out by results: sales in the first quarter of 2006 were in excess of £500,000, and we now have more than 20 new potential customers in our pipeline for online training aimed at enhancing the sales of their particular products or servic... | 3 |
1cons | 60806922.txt_b0 | 60806922.txt | £
750
170,307
276,067
128,935
276,817
299,242
Floating rate financial assets include cash, and term deposits.
(b) Financial Liabilities
The interest rate profile of the Group's financial liabilities at 31 December was as follows:-
2005
Sterling
2004 Sterling
Total
£ 54,310 54,310
Floating Rate
Liabilities £... | 4 |
1cons | 60806922.txt_b1 | 60806922.txt | options for the Company's shares which have been granted to directors and other parties. The share options currently in existence are as follows:-
Date granted
16 November 1999 16 November 1999
Parties
Director Other
Exercise price
0.2p 0.2p
Number of shares
2,642,500 131,500
Final exercise date
16 November 2009 ... | 5 |
1cons | 60450650.txt_0 | 60450650.txt | Report and Financial Statements 31 December 2003
HIGHCROFT INVESTMENTS PLC
Dividends for 2003 are up 8.4% on 2002......... We look forward to another successful year in 2004.
Gavin Kingerlee, Chairman
Contents
1 2003 the Year in Brief 2 Chairman's Statement 4 Corporate Governance 6 Directors and Advisers 7 Repo... | 0 |
1cons | 60450650.txt_1 | 60450650.txt | Adjusted earnings per share up 6.3% to 22.1p q Continuing emphasis on the property portfolio q Net asset value per share up 9.9% to 656p, its highest ever level q Total dividends up 8.4% to 11.0p per share q Final dividend of 7.25p payable on 26 May 2004 q Annual General Meeting on Wednesday 19 May 2004
Total net ass... | 1 |
1cons | 60450650.txt_2 | 60450650.txt | ' broad objectives remain to enhance shareholder value through a combination of rising asset values and increasing profits, intended to sustain long term dividend growth. We set out our strategy in mid-2002 and, as last year, review here our performance against our principal objectives.
q "To modify the balance of the ... | 2 |
1cons | 60450650.txt_3 | 60450650.txt | efficiently as possible. The funds generated will be reinvested in the property portfolio from which we expect to earn higher income yields than from listed investments."
q "To maintain a smaller, though still significant, proportion of funds in listed investments in order to keep a broad risk profile. It is not the in... | 3 |
1cons | 60450650.txt_b0 | 60450650.txt | TAIN MEMBERS
8. That, in view of the failure of the Board of Directors to implement expediently the expansion of the property portfolio of the company since June 2002, the directors of the company be urged to formulate and then submit to ordinary shareholders of the company for approval by no later than the date of the... | 4 |
1cons | 60450650.txt_b1 | 60450650.txt | behalf at the Annual General Meeting to be held on 19 May 2004 and at any adjournment thereof.
I/We desire to vote:
RESOLUTIONS
ORDINARY RESOLUTIONS
1. To receive and consider the report and financial statements for the year ended 31 December 2003
2. To approve a final dividend of 7.25p per share on the ordinary sha... | 5 |
1cons | 60762006.txt_0 | 60762006.txt | ANNUAL REPORT 2005
Net Insight
2005 in brief
3
Statement from the CEO
4
Operation and vision
6
Net Insight's offering
8
Market segments
Professional media industry
11
Core networks
12
Triple play
13
Customer profile
14
Product development
16
Platform and products
18
Organization and employees
20... | 0 |
1cons | 60762006.txt_1 | 60762006.txt | register their intention with the company not later than 4:00 PM on March 28, 2006 in one of the following ways:
Telephone: +46 (0) 8-685 04 00, fax +46 (0) 8-685 04 20 E-mail: info@netinsight.net Mail: Net Insight, Box 42093, 126 14 Stockholm
Nominee shareholders, in order to participate, must temporarily re-register... | 1 |
1cons | 60762006.txt_2 | 60762006.txt | 2005 IN BRIEF
The Group's net sales increased by 124 percent to SEK 90.9 million (40.5). Strong gross margin of 63 percent. Profit/loss before tax SEK -59.6 million (-82.4). Earnings per share after tax totaled SEK -0.17 (-0.29). Increase in average order value and important new customers within the professional media... | 2 |
1cons | 60762006.txt_3 | 60762006.txt | 4 -0.49
56 85 0.49 69
1) Not adjusted in accordance with IFRS.
Revenue per country/region %
Revenue per product/service %
Sweden
5.0
Europe excluding Sweden 67.8
North America
27.7
Asia
0.5
Hardware
89.2
Software, support,
training and service 10.8
Net Insight in brief Net Insight develops and sells netw... | 3 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.